PLoS ONE (Jan 2014)

Correction: ERManI Is a Target of miR-125b and Promotes Transformation Phenotypes in Hepatocellular Carcinoma (HCC).

  • Shujuan Pan,
  • Xiaoyun Cheng,
  • Hongan Chen,
  • Patricia D. Castro,
  • Michael M. Ittmann,
  • Anne W. Hutson,
  • Susan K. Zapata,
  • Richard N. Sifers

DOI
https://doi.org/10.1371/annotation/a8938c97-3002-45c3-bde5-91952a5fa4eb
Journal volume & issue
Vol. 9, no. 1

Abstract

Read online

No abstracts available.